Payers ‘can’t ignore assisted living,’ former senators say
By
Lois A. Bowers
Mar 27, 2017
Former Sens. Tom Daschle and Bill Frist showed prescience at the NIC Spring Investment Forum when they said that any reform to the Affordable Care Act would need bipartisan support to be successful. They...
Memory care initial rates average 8.5% below average asking rate: NIC
By
Amy Novotney
Sep 10, 2020
Average initial rates for residents moving into independent living, assisted living and memory care segments were below average asking rates amid the COVID-19 pandemic, with monthly spreads generally largest...
Kim Campbell is on a memory care mission
By
Lois A. Bowers
Oct 02, 2017
Three years after Glen Campbell received his Alzheimer’s diagnosis, his wife, Kim, didn’t know that memory care communities existed. Now she’s on a mission to ensure that other family...
More news for Friday, Aug. 30
Aug 30, 2019
1 year later: An update on the Welltower-ProMedica partnership … New York Times opinion piece says assisted living is “how not to grow old in America” … Drinking coffee may ease tremors in...
More news for Tuesday, Feb. 7
Feb 06, 2017
Search for Alzheimer’s drugs is more urgent than ever … How would Republican plans for Medicaid block grants actually work? … Long-term care advocates call on Canadian government to invest...
It’s a good time for a move to senior living, data show
By
Lois A. Bowers
Apr 20, 2016
Annual senior living costs increased 2.7% from 2014 to 2016, according to new data released by senior living referral service A Place for Mom. The increase outpaces inflation but still beats the housing...
38 senators call for more Alzheimer’s funding
By
Lois A. Bowers
Apr 16, 2018
Thirty-eight senators have asked leaders of the Senate Committee on Appropriations and its Subcommittee on Labor, Health and Human Services, and Education to make increased funding for Alzheimer’s...
2 ways to help residents combat dementia
Nov 19, 2015
Recently published research from the United States and Australian reveals two ways to slow or prevent cognitive decline.
Ethical considerations explored for aducanumab in Alzheimer’s disease
Nov 19, 2021
Grounds are insufficient to offer aducanumab (Aduhelm) for moderate, advanced Alzheimer’s dementia or for individuals without biomarker evidence of brain ß-amyloid, according to a position statement.
15 percent of off-label antipsychotic use in assisted living may be inappropriate, but nursing home reduction...
By
Kimberly Bonvissuto
Sep 14, 2021
The rate of potentially inappropriate prescribing of drugs in assisted living is 15% for antipsychotics and 21% for antianxiety medications, according to the authors of a new study published in JAMDA,...